Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
PZ HTL SA
GLOBETECH PUBLISHING LLC

Molecular Switch That Controls Formation of Bacterial Biofilms Identified and Characterized

By BiotechDaily International staff writers
Posted on 06 May 2013
Researchers studying the molecular mechanism that induces free-living bacteria to adhere together in a biofilm have identified the SinR gene as the master regulator of this transformation.

Biofilms have been found to be involved in a wide variety of microbial infections in the body, by one estimate 80% of all infections. Infectious processes in which biofilms have been implicated include common problems such as urinary tract infections, catheter infections, middle-ear infections, formation of dental plaque, gingivitis, coating contact lenses, and less common but more lethal processes such as endocarditis, infections in cystic fibrosis, and infections of permanent indwelling devices such as joint prostheses and heart valves. More recently, it has been noted that bacterial biofilms may impair cutaneous wound healing and reduce topical antibacterial efficiency in healing or treating infected skin wounds.

Bacteria living in a biofilm usually have significantly different properties from free-floating bacteria of the same species, as the dense and protected environment of the film allows them to cooperate and interact in various ways. One benefit of this environment is increased resistance to detergents and antibiotics, as the dense extracellular matrix and the outer layer of cells protect the interior of the community. In some cases, antibiotic resistance can be increased by more than a thousand times.

Microbes form a biofilm in response to many factors, which may include cellular recognition of specific or nonspecific attachment sites on a surface, nutritional cues, or in some cases, by exposure of free-living planktonic cells to subinhibitory concentrations of antibiotics. When a cell switches to the biofilm mode of growth, it undergoes a phenotypic shift in behavior in which large suites of genes are differentially regulated.

Investigators at Newcastle University (United Kingdom) examined the mode of action of the SinR gene in the Gram-positive model organism Bacillus subtilis. They reported in the April 12, 2013, issue of the Journal of Biological Chemistry that the activity of SinR was controlled by its antagonists, SinI, SlrA, and SlrR. The interaction of these four proteins formed a switch, which determined whether SinR could inhibit biofilm formation by its repression of a number of extracellular matrix-associated operons.

To determine the thermodynamic and kinetic parameters governing the protein-protein and protein-DNA interactions at the heart of this molecular switch, the investigators analyzed the protein-protein and protein-DNA interactions by isothermal titration calorimetry and surface plasmon resonance. They also determined the crystal structure of SinR in complex with DNA, which revealed the molecular basis of base-specific DNA recognition by SinR and suggested that the most effective means of transcriptional control occurred by the looping of promoter DNA.

Senior author Dr. Richard Lewis, professor of structural biology at Newcastle University, said, “SinR is a bit like a rocker switch—a domestic light switch, for instance. In the "down" position, when SinR is bound to DNA, the proteins required to make a biofilm are turned off and the bacteria are free to move. In the "up" position, SinR is no longer bound to DNA and instead interacts with other proteins, and the biofilms genes are turned on.”

Related Links:

Newcastle University



comments powered by Disqus

Channels

Drug Discovery

view channel
Image: The nano-cocoon drug delivery system is biocompatible, specifically targets cancer cells, can carry a large drug load, and releases the drugs very quickly once inside the cancer cell. Ligands on the surface of the \"cocoon\" trick cancer cells into consuming it. Enzymes (the “worms\" in this image) inside the cocoon are unleashed once inside the cell, destroying the cocoon and releasing anticancer drugs into the cell (Photo courtesy of Dr. Zhen Gu, North Carolina State University).

Novel Anticancer Drug Delivery System Utilizes DNA-Based Nanocapsules

A novel DNA-based drug delivery system minimizes damage to normal tissues by utilizing the acidic microenvironment inside cancer cells to trigger the directed release of the anticancer drug doxorubicin (DOX).... Read more

Lab Technologies

view channel

Experimental Physicists Find Clues into How Radiotherapy Kills Cancer Cells

A new discovery in experimental physics has implications for a better determination of the process in which radiotherapy destroys cancer cells. Dr. Jason Greenwood from Queen’s University Belfast (Ireland) Center for Plasma Physics collaborated with scientists from Italy and Spain on the work on electrons, and published... Read more

Business

view channel

Interest in Commercial Applications for Proteomics Continues to Grow

Increasing interest in the field of proteomics has led to a series of agreements between private proteomic companies and academic institutions as well as deals between pharmaceutical companies and novel proteomics innovator biotech companies. Proteomics is the study of the structure and function of proteins.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.